Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
EIF4E2 Antibody (OTI1F11) - Azide and BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP271468
Description
EIF4E2 Monoclonal specifically detects EIF4E2 in Human, Mouse samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, CyTOF-ready.Specifications
EIF4E2 | |
Monoclonal | |
LYOPH | |
Western Blot 1:1000-2000, Flow Cytometry 1:100, Immunohistochemistry 1:150, Immunocytochemistry/Immunofluorescence 1:100, CyTOF-ready | |
4EHP, 4E-LP, eIF4E type 2, eIF-4E type 2, EIF4EL3, eIF4E-like cap-binding protein, eIF4E-like protein 4E-LP, eukaryotic translation initiation factor 4E family member 2, Eukaryotic translation initiation factor 4E homologous protein, eukaryotic translation initiation factor 4E member 2, eukaryotic translation initiation factor 4E type 2, Eukaryotic translation initiation factor 4E-like 34E-LP, IF4e, mRNA cap-binding protein 4EHP, mRNA cap-binding protein type 3 | |
Mouse | |
28.2 kDa | |
100 μg | |
Primary | |
Reconstitute with PBS (pH 7.3). To use this carrier-free antibody for conjugation experiments, another round of desalting is highly recommended. | |
Store at -20°C. Avoid freeze-thaw cycles. | |
IgG1 |
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, CyTOF | |
OTI1F11 | |
Unconjugated | |
Lyophilized from PBS (pH 7.3) with 8% Trehalose with No Preservative | |
EIF4E2 | |
Full length human recombinant protein of human EIF4E2 (NP_004837) produced in HEK293T cell. | |
Affinity Purified | |
DNA Repair, DNA replication Transcription Translation and Splicing | |
9470 | |
Human, Mouse | |
Lyophilized |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction